Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aharon G Freud

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Journal of the National Cancer Institute|October 7, 2004
Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorderSameek Roychowdhury, Robert A Baiocchi, Srinivas Vourganti, et al.
Immunity|May 15, 2016
A Progenitor Cell Expressing Transcription Factor RORγt Generates All Human Innate Lymphoid Cell SubsetsSteven D Scoville, Bethany L Mundy-Bosse, Michael H Zhang, et al.
Immunity|March 15, 2015
Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and functionYoucai Deng, Yann Kerdiles, Jianhong Chu, et al.
JTO Clinical and Research Reports|September 30, 2021
Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research AutopsyHui-Zi Chen, Russell Bonneville, Anoosha Paruchuri, et al.
Molecular Cancer Therapeutics|January 9, 2020
Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion CholangiocarcinomaMelanie A Krook, Alexandria Lenyo, Max Wilberding, et al.
Cold Spring Harbor Molecular Case Studies|August 3, 2019
Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsyMelanie A Krook, Russell Bonneville, Hui-Zi Chen, et al.
The Journal of Clinical Investigation|October 25, 2016
MicroRNA-29b mediates altered innate immune development in acute leukemiaBethany L Mundy-Bosse, Steven D Scoville, Li Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2019
EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid LeukemiaMarius Bill, Aparna Pathmanathan, Malith Karunasiri, et al.
Haematologica|May 30, 2024
Myeloid neoplasm with histiocytosis and spleen tyrosine kinase fusion responds to fostamatinibZachary Risch, Benjamin H Kaffenberger, Catherine G Chung, et al.
Leukemia|December 22, 2025
Leukemia-driven expansion of type 3 innate lymphoid cell facilitates a pro-tumoral microenvironment in acute myeloid leukemiaThanh Thanh T Dinh, Matthew R Lordo, Amy Y Zhang, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Journal of the National Cancer Institute|October 7, 2004
Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorderSameek Roychowdhury, Robert A Baiocchi, Srinivas Vourganti, et al.
Immunity|May 15, 2016
A Progenitor Cell Expressing Transcription Factor RORγt Generates All Human Innate Lymphoid Cell SubsetsSteven D Scoville, Bethany L Mundy-Bosse, Michael H Zhang, et al.
Immunity|March 15, 2015
Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and functionYoucai Deng, Yann Kerdiles, Jianhong Chu, et al.
JTO Clinical and Research Reports|September 30, 2021
Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research AutopsyHui-Zi Chen, Russell Bonneville, Anoosha Paruchuri, et al.
Molecular Cancer Therapeutics|January 9, 2020
Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion CholangiocarcinomaMelanie A Krook, Alexandria Lenyo, Max Wilberding, et al.
Cold Spring Harbor Molecular Case Studies|August 3, 2019
Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsyMelanie A Krook, Russell Bonneville, Hui-Zi Chen, et al.
The Journal of Clinical Investigation|October 25, 2016
MicroRNA-29b mediates altered innate immune development in acute leukemiaBethany L Mundy-Bosse, Steven D Scoville, Li Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2019
EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid LeukemiaMarius Bill, Aparna Pathmanathan, Malith Karunasiri, et al.
Haematologica|May 30, 2024
Myeloid neoplasm with histiocytosis and spleen tyrosine kinase fusion responds to fostamatinibZachary Risch, Benjamin H Kaffenberger, Catherine G Chung, et al.
Leukemia|December 22, 2025
Leukemia-driven expansion of type 3 innate lymphoid cell facilitates a pro-tumoral microenvironment in acute myeloid leukemiaThanh Thanh T Dinh, Matthew R Lordo, Amy Y Zhang, et al.
Pageof 9